These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19519386)

  • 1. Metabotropic glutamate receptors in the control of neuronal activity and as targets for development of anti-epileptogenic drugs.
    Tang FR; Bradford HF; Ling EA
    Curr Med Chem; 2009; 16(17):2189-204. PubMed ID: 19519386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonists and antagonists of metabotropic glutamate receptors: anticonvulsants and antiepileptogenic agents?
    Tang FR
    Curr Neuropharmacol; 2005 Oct; 3(4):299-307. PubMed ID: 18369399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate metabotropic receptors as targets for drug therapy in epilepsy.
    Moldrich RX; Chapman AG; De Sarro G; Meldrum BS
    Eur J Pharmacol; 2003 Aug; 476(1-2):3-16. PubMed ID: 12969743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of seizures induced by homocysteic acid in immature rats by metabotropic glutamate group II and group III receptor agonists.
    Folbergrová J; Haugvicová R; Mares P
    Brain Res; 2001 Jul; 908(2):120-9. PubMed ID: 11454322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabotropic glutamate receptors as a possible target of antiepileptic therapy].
    Lojková D; Mares P
    Cesk Fysiol; 2007; 56(2):60-8. PubMed ID: 17691482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of calcium channels by group I and group II metabotropic glutamate receptors in dentate gyrus neurons from patients with temporal lobe epilepsy.
    Schumacher TB; Beck H; Steffens R; Blümcke I; Schramm J; Elger CE; Steinhäuser C
    Epilepsia; 2000 Oct; 41(10):1249-58. PubMed ID: 11051119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy.
    Alexander GM; Godwin DW
    Epilepsy Res; 2006 Sep; 71(1):1-22. PubMed ID: 16787741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttreatment with group II metabotropic glutamate receptor agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate is only weakly effective on seizures in immature rats.
    Folbergrová J; Druga R; Tsenov G; Haugvicová R; Otáhal J
    Brain Res; 2009 Jun; 1273():144-54. PubMed ID: 19341715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabotropic Glutamate Receptors and Interacting Proteins in Epileptogenesis.
    Qian F; Tang FR
    Curr Neuropharmacol; 2016; 14(5):551-62. PubMed ID: 27030135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of metabotropic glutamate receptors in seizures and epilepsy.
    Doherty J; Dingledine R
    Curr Drug Targets CNS Neurol Disord; 2002 Jun; 1(3):251-60. PubMed ID: 12769618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined pathogenetic therapy of epilepsy in experiment].
    Karpova MN; Abrosimov IIu; Kryzhanovskiĭ GN
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(7):41-5. PubMed ID: 9511214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-epileptogenic and anticonvulsant activity of L-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist.
    Abdul-Ghani AS; Attwell PJ; Singh Kent N; Bradford HF; Croucher MJ; Jane DE
    Brain Res; 1997 May; 755(2):202-12. PubMed ID: 9175888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect caused by MPEP, an antagonist of metabotropic glutamate receptor mGluR5, on seizures induced by pilocarpine in 21-day-old rats.
    Jesse CR; Savegnago L; Rocha JB; Nogueira CW
    Brain Res; 2008 Mar; 1198():197-203. PubMed ID: 18242586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of metabotropic glutamate receptors I and III in mouse strains with different susceptibility to experimental temporal lobe epilepsy.
    Chen J; Larionov S; Pitsch J; Hoerold N; Ullmann C; Elger CE; Schramm J; Becker AJ
    Neurosci Lett; 2005 Mar; 375(3):192-7. PubMed ID: 15694259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat.
    Miyamoto M; Ishida M; Shinozaki H
    Neuroscience; 1997 Mar; 77(1):131-40. PubMed ID: 9044381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats.
    Tang E; Yip PK; Chapman AG; Jane DE; Meldrum BS
    Eur J Pharmacol; 1997 May; 327(2-3):109-15. PubMed ID: 9200548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mGlu7 receptor provides protective effects against epileptogenesis and epileptic seizures.
    Girard B; Tuduri P; Moreno MP; Sakkaki S; Barboux C; Bouschet T; Varrault A; Vitre J; McCort-Tranchepain I; Dairou J; Acher F; Fagni L; Marchi N; Perroy J; Bertaso F
    Neurobiol Dis; 2019 Sep; 129():13-28. PubMed ID: 31051234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Modifying Effects of the Spider Toxin Parawixin2 in the Experimental Epilepsy Model.
    Godoy LD; Liberato JL; Celani MVB; Gobbo-Neto L; Lopes NP; Dos Santos WF
    Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28841161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
    Gasparini F; Bruno V; Battaglia G; Lukic S; Leonhardt T; Inderbitzin W; Laurie D; Sommer B; Varney MA; Hess SD; Johnson EC; Kuhn R; Urwyler S; Sauer D; Portet C; Schmutz M; Nicoletti F; Flor PJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1678-87. PubMed ID: 10336568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.